Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC)
CL-CA-P01
Phase 3 mab terminated
Quick answer
Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) for Stage IV Melanoma is a Phase 3 program (mab) at LISATA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LISATA THERAPEUTICS, INC.
- Indication
- Stage IV Melanoma
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated